FY2018 EPS Estimates for Phibro Animal Health Corp (PAHC) Raised by Gabelli

Phibro Animal Health Corp (NASDAQ:PAHC) – Stock analysts at Gabelli increased their FY2018 earnings estimates for Phibro Animal Health in a research note issued to investors on Wednesday. Gabelli analyst K. Kedra now anticipates that the company will post earnings of $1.70 per share for the year, up from their prior estimate of $1.55. Gabelli also issued estimates for Phibro Animal Health’s FY2019 earnings at $1.90 EPS.

Phibro Animal Health (NASDAQ:PAHC) last issued its earnings results on Monday, February 5th. The company reported $0.44 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.38 by $0.06. Phibro Animal Health had a return on equity of 40.49% and a net margin of 7.90%. The firm had revenue of $205.90 million for the quarter, compared to analysts’ expectations of $194.90 million. During the same period in the previous year, the firm posted $0.39 earnings per share. The business’s revenue was up 7.5% compared to the same quarter last year.

Several other brokerages have also recently issued reports on PAHC. Zacks Investment Research raised Phibro Animal Health from a “sell” rating to a “hold” rating in a report on Monday, January 8th. BidaskClub cut Phibro Animal Health from a “sell” rating to a “strong sell” rating in a report on Friday, December 29th. Credit Suisse Group boosted their price objective on Phibro Animal Health from $37.00 to $39.00 and gave the stock a “neutral” rating in a research note on Tuesday. ValuEngine cut Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Thursday, November 9th. Finally, Piper Jaffray Companies reissued a “buy” rating and set a $42.00 price objective on shares of Phibro Animal Health in a research note on Friday, November 10th. Three equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $38.20.

Shares of Phibro Animal Health (PAHC) traded down $0.85 during mid-day trading on Thursday, hitting $35.75. The stock had a trading volume of 25,332 shares, compared to its average volume of 75,134. Phibro Animal Health has a 1 year low of $26.70 and a 1 year high of $40.25. The company has a quick ratio of 1.85, a current ratio of 3.12 and a debt-to-equity ratio of 1.82. The company has a market capitalization of $1,460.65, a PE ratio of 23.01, a price-to-earnings-growth ratio of 3.97 and a beta of 1.18.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, March 28th. Investors of record on Wednesday, March 7th will be issued a $0.10 dividend. The ex-dividend date is Tuesday, March 6th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.12%. Phibro Animal Health’s payout ratio is 26.14%.

Several hedge funds and other institutional investors have recently made changes to their positions in PAHC. Vanguard Group Inc. lifted its holdings in Phibro Animal Health by 3.0% during the second quarter. Vanguard Group Inc. now owns 1,780,880 shares of the company’s stock worth $65,982,000 after buying an additional 51,474 shares during the period. Copper Rock Capital Partners LLC increased its position in shares of Phibro Animal Health by 9.6% during the fourth quarter. Copper Rock Capital Partners LLC now owns 631,876 shares of the company’s stock worth $21,326,000 after purchasing an additional 55,235 shares in the last quarter. FMR LLC increased its position in shares of Phibro Animal Health by 31.9% during the second quarter. FMR LLC now owns 584,463 shares of the company’s stock worth $21,654,000 after purchasing an additional 141,274 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of Phibro Animal Health by 11.8% during the third quarter. Dimensional Fund Advisors LP now owns 465,297 shares of the company’s stock worth $17,239,000 after purchasing an additional 49,296 shares in the last quarter. Finally, Ameriprise Financial Inc. increased its position in shares of Phibro Animal Health by 26.7% during the third quarter. Ameriprise Financial Inc. now owns 430,656 shares of the company’s stock worth $15,958,000 after purchasing an additional 90,660 shares in the last quarter. Hedge funds and other institutional investors own 48.31% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece was originally reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this piece on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this piece can be viewed at https://sportsperspectives.com/2018/02/08/fy2018-eps-estimates-for-phibro-animal-health-corp-pahc-raised-by-gabelli.html.

About Phibro Animal Health

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Earnings History and Estimates for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply